# Oral Amantadine, IV Amantadine and Hemodynamic Response to Laryngoscopy

> **NCT03612921** · PHASE2 · UNKNOWN · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- Intubation, Intratracheal

## Interventions

- **DRUG:** oral Amantadine sulfate
- **DRUG:** i.v Amantadine Sulfate
- **DRUG:** placebo tablet

## Key facts

- **NCT ID:** NCT03612921
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-15
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03612921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03612921, "Oral Amantadine, IV Amantadine and Hemodynamic Response to Laryngoscopy". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03612921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*